-
Top novel drug approvals: February 2019
europeanpharmaceuticalreview
April 12, 2019
Cablivi and Egaten were the two top novel drugs approved last month, with a focus on parasitic infestation and the rare disorder, aTTP…
-
3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility
europeanpharmaceuticalreview
April 12, 2019
3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility.
-
Big pharma blamed for skyrocketing US drug prices
europeanpharmaceuticalreview
April 12, 2019
Executives blamed high drug prices on the drugmakers and their pursuit of profits…
-
Millions on insomnia drug would sleep through a fire alarm
europeanpharmaceuticalreview
April 12, 2019
A study has reported that millions currently taking benzodiazepines to help them sleep would not hear a fire alarm, thus warning of possible dangers…
-
AstraZeneca and Daiichi Sankyo sign $6.9bn cancer drug development deal
pharmaceutical-technology
April 11, 2019
AstraZeneca has entered a deal worth up to $6.9bn with Daiichi Sankyo to develop and commercialise cancer drug trastuzumab deruxtecan...
-
More Alzheimer's Drug Trial Failures: Are Researchers on the Wrong Track?
drugs
April 11, 2019
Amyloid beta has long been a prime suspect in Alzheimer's disease, since abnormal levels of the protein form disruptive plaques between patients' brain cells...
-
FDA Approves Two-Drug HIV Therapy for Previously Untreated Patients
americanpharmaceuticalreview
April 11, 2019
FDA Approves Two-Drug HIV Therapy for Previously Untreated Patients.
-
Catalent expands OptiMelt hot melt extrusion capabilities
cphi-online
April 11, 2019
Catalent Pharma Solutions has invested a further $5 million at the company’s Somerset, New Jersey, drug development center of excellence to expand...
-
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund
pharmafile
April 11, 2019
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund.
-
FDA: Patients Should Not Abruptly Stop Taking a Prescribed Opioid
drugs
April 11, 2019
FDA: Patients Should Not Abruptly Stop Taking a Prescribed Opioid.